Clinical Trial Update: Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating desogestrel for improving ventilatory control in congenital central hypoventilation syndrome; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Central Hypoventilation Syndrome

Drugs mentioned

• Desogestrel (Desogestrel)

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Congenital Central Hypoventilation Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2023-09-28